Evan Gershkovich Trial Begins
Sort by
8 items
Filter
-
The Hill - Politics
12:30 Report — Tides begin to turn on Biden post-debate
{beacon} 12:30 REPORT It’s Wednesday. Happy Fourth of July eve! Where are you watching fireworks tomorrow night? Here’s what’s happening today: President Biden gets more bad news as his campaign looks to reassure nervous Democrats after the debate ...Joe Biden -
The Wall Street Journal - World
Turkish Inflation Moves Past Peak as High Rates Begin to Pay Off
Turkish consumer inflation looks to have begun a strong downward slide, says Bartosz Sawicki, market analyst at fintech Conotoxia.Turkey -
CBS News - Top stories
Bob Menendez's defense rests without senator testifying in bribery trial
Jurors are expected to have the case by the end of next week. -
The Guardian - World
Euro 2024: quarter-final buildup begins as England’s full squad of 26 train – live
All the latest news as we look ahead to the quarter-finalsFootball Daily podcast | Golden Boot | And email WillBut it wasn’t just fans of teams who’ve progressed filling their streets yesterday. Here’s a taste of the welcome back Georgia got in ... -
MarketWatch - Business
Annovis Bio’s stock rockets 76% after reporting positive data in Parkinson’s disease trial
The stock is on track for its best performance since May 21, 2021, when it gained 127%. -
ABC News - World
Former Northern Ireland unionist leader ordered to stand trial for alleged sex offenses
A judge has ordered the former leader of Northern Ireland’s biggest unionist party to stand trial on charges of rape and sexual offenses -
ESPN - Sports
McLaughlin-Levrone sets tone, heartbreak for Mu at 2024 U.S. track and field trials
From Sydney McLaughlin-Levrone's world record time to Lolo Jones' first Olympic trials in 12 years, here are the biggest surprises and takeaways from an action-packed week at Hayward Field in Eugene, Oregon. -
CNBC - Business
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Brain implant company Paradromics is preparing for human trials, while President Biden's poor debate performance affected health-care stocks.